Sorry, Mrs. Sabourin, I'll move on. It's okay. You've given me something so at least I understand the rationale.
I'd like to get in one more question. You may not be able to answer, but I'm wondering why Health Canada approved renal denervation surgery under its access to care programs when the one study that looked at safety and efficacy was funded by the company that makes the $6,000 catheters that are used in the procedure.